Tag debug info: client: {"assets":{},"datasets":{},"live":{},"projects":{},"users":{},"observable":{"assets":{},"datasets":{},"live":{},"projects":{},"users":{}}} Now: 1770554754346 Cache Key: cqdTagPageBySlug:multiple-sclerosis-ms fetchCache[cqdTagPageBySlug:multiple-sclerosis-ms].expirationTime: falsey fetchCache[cqdTagPageBySlug:multiple-sclerosis-ms]. seconds remaining: falsey All fetchCache expiration times: -- Key: cqdNotFoundPage, seconds remaining: -1703 -- Key: cqdTagPageBySlug:lifu, seconds remaining: -20158 -- Key: cqdPostsByTag:cqd-migrated-tag-24857,1,10, seconds remaining: -20095 -- Key: cqdTagPageBySlug:shwachman-diamond-syndrome-sds, seconds remaining: -14241 -- Key: cqdPostsByTag:cqd-migrated-tag-22988,1,10, seconds remaining: -14170 -- Key: cqdTagPageBySlug:hospital-acquired-infections, seconds remaining: -11816 -- Key: cqdPostsByTag:cqd-migrated-tag-1497,1,10, seconds remaining: -11751 -- Key: cqdTagPageBySlug:chirag-shah, seconds remaining: -7132 -- Key: cqdPostsByTag:cqd-migrated-tag-4363,1,10, seconds remaining: -7059 -- Key: cqdTagPageBySlug:clonal-hematopoiesis-of-indeterminate-potential-chip, seconds remaining: -4795 -- Key: cqdPostsByTag:cqd-migrated-tag-21703,1,10, seconds remaining: -4729 -- Key: cqdTagPageBySlug:cervical-cancer, seconds remaining: -1703 -- Key: cqdPostsByTag:cqd-migrated-tag-2955,1,10, seconds remaining: -1630 -- Key: cqdTagPageBySlug:tyrosine-kinase-inhibitors-tkis, seconds remaining: 953 -- Key: cqdPostsByTag:cqd-migrated-tag-22438,1,10, seconds remaining: 1031 -- Key: cqdTagPageBySlug:systemic-lupus-erythematosus-sle, seconds remaining: 2481 -- Key: cqdPostsByTag:cqd-migrated-tag-1448,2,10, seconds remaining: 2543 conditions: -- false, -- NA, -- NA, -- NA -- false Cache miss for key cqdTagPageBySlug:multiple-sclerosis-ms - retrieving from Sanity CCCache.dataFetchCount: 21690 Cache cleanup seconds remaining: 5759
Advertisement
Advertisement
Tag: multiple sclerosis (MS)
Study shows short-term behavioral training can yield objective and subjective gains
A co-author of the new recommendations shares the updates you need to know
Rebound risk is shaped by patient characteristics and mechanism of action of current DMT
First-of-kind prediction model demonstrates high consistency across internal and external validation
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Real-world study also finds no significant rise in ocrelizumab-related risk with advanced age
Machine learning study associates discrete neuropsychological testing profiles with neurodegeneration
This MRI marker of inflammation can help differentiate MS from mimics early in the disease
Focuses include real-world research, expanding access and more
Case-control study yields evidence of epigenetic aging in pediatric-onset MS
Novel insights from a postmortem study combining imaging, pathology and clinical perspectives
Rendered: Sun Feb 08 2026 12:45:54 GMT+0000 (Coordinated Universal Time)
9500 Euclid Avenue, Cleveland, Ohio 44195 |
800.223.2273 | ©
2026 Cleveland Clinic. All Rights Reserved.